Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
批准号:
10631694
负责人:
Renee A. Heffron
金额:
$54.14万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2025-05-31
关键词:
AIDS preventionAdherenceAdvocateAfricaAttentionBuprenorphineCapitalCitiesCocaineCommunicable DiseasesCommunitiesConsensusConsolidated Framework for Implementation ResearchConsultationsDataDrug usageDrug userEducational workshopEnsureEpidemicEquipmentFundingGuidelinesHIVHIV SeronegativityHIV antiretroviralHarm ReductionHealthHepatitis CHeroinHuman immunodeficiency virus testInjectableInjecting drug userInjectionsInstitutesInterventionInterviewKnowledgeLocationMeasuresMethodsModelingNeedle-Exchange ProgramsNeedlesOralPersonsPharmaceutical PreparationsPlasmaPolice ForcesPoliciesPopulationPrevalencePreventionPrevention GuidelinesProviderQualitative ResearchReportingResearchRiskScientistService delivery modelService provisionServicesSiteSurveysSyringesTenofovirUgandaUpdateWorkaddictionantiretroviral therapybasebudget impactcommunity based participatory researchcostcost estimateevidence baseexperiencefollow-upimplementation scienceimprovedinfancymedication-assisted treatmentmembermultidisciplinarynovelpathogenpre-exposure prophylaxispreferenceprescription pain relieverprevention serviceprogramsrecruitscale upservice deliverysexsocialsocial stigmatraffickingtransmission processtreatment programuptakewillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
In the past decade, Uganda seen increases – as large as 10-fold – in the number of people who use drugs
(PWUD) and the risk for HIV transmission through shared injection equipment, a common practice in this setting
with low access to clean equipment. HIV prevalence among PWUD has been estimated to be as high as
45%, highlighting the importance of widescale access to HIV treatment and prevention for PWUD,
including oral pre-exposure prophylaxis (PrEP). PrEP was integrated into HIV prevention guidelines in
Uganda in 2016 and PEPFAR funding has been supporting targeted rollout to key populations, including PWUD.
However, <250 people currently accessing PrEP have identified as PWUD, indicating a large gap in prevention
and an opportunity to optimize PrEP delivery for PWUD. For PWUD living with HIV, antiretroviral treatment has
been integrated into medication assisted treatment (MAT) programs and needle and syringe exchange programs
(NSP), by leveraging providers who empathize with addiction and have experience combating stigma associated
with drug use. We hypothesize that a similar approach can be done for PrEP by integrating PrEP delivery
into MAT and NSP programs and we proposed a staged approach to conduct formative work and refine
two integrated programs (PrEP + MAT and PrEP + NSP), to pilot these programs and assess PrEP uptake,
retention, and adherence and to conduct costing research to directly inform policy guidance. Our work
will be conducted with attention to several constructs within the Consolidated Framework for Implementation
Research and grounded in a participatory approach with members of the largest harm reduction network, police
force, and PWUD in Uganda as project advisors. Specifically, we aim to: 1) conduct qualitative research to
explore preferences for HIV prevention services and willingness to use/prescribe PrEP among PWUD and
providers of a) oral PrEP and b) services for PWUD in Kampala, Uganda; 2) refine programs for community-
based NSP + PrEP and facility-based MAT + PrEP; 3) compare PrEP uptake, retention, and adherence when
PrEP is integrated into community-based NSP versus facility-based MAT to PWUD; and 4) estimate the
programmatic costs and conduct budget impact analysis for integrating PrEP into our MAT and NSP programs.
Impact. The proposed work will provide robust evidence about how to optimize integrated harm reduction and
PrEP delivery to PWUD in Uganda and similar settings. With direct engagement from members of the Ugandan
Ministry of Health on our investigative team, our findings will be immediately useful for policy guidelines and to
guide programmatic scale-up. This work will be relevant to the US and globally as a demonstration of co-located
harm reduction and HIV prevention services for PWUD and it will provide some of the first data on PrEP
adherence and retention among PWUD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SWG 2
-
批准号:10846993
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2023
-
负责人:Renee A. Heffron
-
依托单位:
Effectiveness of PrEP product choice on HIV prevention coverage among young women in Kenya seeking reproductive health services
-
批准号:10761048
-
项目类别:
-
资助金额:$69.33万
-
财政年份:2023
-
负责人:Renee A. Heffron
-
依托单位:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
-
批准号:10744381
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2022
-
负责人:Renee A. Heffron
-
依托单位:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIVprevention products
-
批准号:10642471
-
项目类别:
-
资助金额:$12.71万
-
财政年份:2022
-
负责人:Renee A. Heffron
-
依托单位:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIVprevention products
-
批准号:10548809
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2022
-
负责人:Renee A. Heffron
-
依托单位:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
-
批准号:10684112
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2022
-
负责人:Renee A. Heffron
-
依托单位:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIV prevention products
-
批准号:10322040
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2021
-
负责人:Renee A. Heffron
-
依托单位:
Feasibility pilot of home-based STI testing and risk self-assessment among adolescent girls in South Africa to trigger PrEP re-start
-
批准号:10678858
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2021
-
负责人:Renee A. Heffron
-
依托单位:
Feasibility pilot of home-based STI testing and risk self-assessment among adolescent girls in South Africa to trigger PrEP re-start
-
批准号:10256147
-
项目类别:
-
资助金额:$14.49万
-
财政年份:2021
-
负责人:Renee A. Heffron
-
依托单位:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIV prevention products
-
批准号:10159602
-
项目类别:
-
资助金额:$15.16万
-
财政年份:2021
-
负责人:Renee A. Heffron
-
依托单位:
Feasibility pilot of home-based STI testing and risk self-assessment among adolescent girls in South Africa to trigger PrEP re-start
-
批准号:10478163
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2021
-
负责人:Renee A. Heffron
-
依托单位:
Implementation science research on PrEP delivery and costing within MAT and NSP services for PWUD in Uganda
-
批准号:10404447
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2020
-
负责人:Renee A. Heffron
-
依托单位:
Alignment of PrEP use with HIV risk in young women
-
批准号:9925907
-
项目类别:
-
资助金额:$22.9万
-
财政年份:2020
-
负责人:Renee A. Heffron
-
依托单位:
Alignment of PrEP use with HIV risk in young women
-
批准号:10082457
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2020
-
负责人:Renee A. Heffron
-
依托单位:
A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)
-
批准号:10355693
-
项目类别:
-
资助金额:$156.2万
-
财政年份:2020
-
负责人:Renee A. Heffron
-
依托单位:
Implementation science research on PrEP delivery and costing within MAT and NSP services for PWUD in Uganda
-
批准号:10223259
-
项目类别:
-
资助金额:$61.3万
-
财政年份:2020
-
负责人:Renee A. Heffron
-
依托单位:
Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women
-
批准号:9344799
-
项目类别:
-
资助金额:$73.72万
-
财政年份:2017
-
负责人:Renee A. Heffron
-
依托单位:
Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women
-
批准号:9901549
-
项目类别:
-
资助金额:$64.87万
-
财政年份:2017
-
负责人:Renee A. Heffron
-
依托单位:
Integrated PrEP and ART delivered in Ugandan public health clinics to improve HIV and ART outcomes for HIV serodiscordant couples
-
批准号:9270226
-
项目类别:
-
资助金额:$66.95万
-
财政年份:2017
-
负责人:Renee A. Heffron
-
依托单位:
Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women
-
批准号:10309664
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2017
-
负责人:Renee A. Heffron
-
依托单位:
海外基金